Skip to main content
. 2020 Nov;9(11):6652–6659. doi: 10.21037/tcr-20-516

Figure 1.

Figure 1

Immunohistochemical analysis of TM9SF4, expression in gastric tissues. (A) gastric control group mucosa; (B) low grade dysplasia; (C) intestinal type gastric cancer; tissue samples. Magnification ×200. (D) Two-way ANOVA followed by Bonferroni post test analysis of TM9SF4 IHC score values of gastric cancer samples at different stages of disease. **, P<0.01, ***, P<0.001 compared to control group (Figure S1A). Value legend. 0–1 = negative/borderline; 1 = weakly expressed; 2 = expressed; 3 = strongly positive. CTR, control gastric mucosa. LGD, low grade dysplasia; EIGC, Early GC intestinal type; LIGC, Late GC intestinal type; EDGC, Early GC diffuse type; LDGC, Late GC diffuse type.